CONFIRMATIVE PHASE III GLOBAL CLINICAL TRIAL OF A BOTANICAL DRUG IN PATIENTS WITH CHRONIC STABLE ANGINA (CAESA): NEW TREATMENT OPTIONS FOR MYOCARDIAL ISCHEMIA HEART DISEASE

Henry Sun,Zhixin Guo,Lingyan Li,Naifeng Wu,Kaijing Yan,Xijun Yan

Journal of the American College of Cardiology（2018）

引用 1|浏览7

暂无评分

摘要

T89, a 3-herb composition drug that improves microcirculation in and increase energy supply to the heart, and reduces blood viscosity in patients with chronic stable angina (A) has been shown to improve clinical outcomes in comparison to current anti-anginal drug (CAAD) such as β-blockers, Ca++

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要